Kingswood Wealth Advisors’s Altimmune ALT Stock Holding History

Kingswood Wealth Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Sell	74,500 -2,000	-3%	-$5.97K	0.01%	907
2026 Q1	$236K	Buy	76,500 +40,500	+113%	+$172K	0.01%	819
2025 Q4	$130K	Buy	36,000 +20,600	+134%	+$89.8K	0.01%	847
2025 Q3	$58.1K	Buy	15,400 +5,000	+48%	+$19.3K	﹤0.01%	789
2025 Q2	$40.2K	Buy	+10,400	New	+$56.3K	﹤0.01%	739

Other funds holding ALT

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BWCS

Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return

BWM

Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

SFWA

Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Kingswood Wealth Advisors's ALT Position: Q2 2026 in Review

Kingswood Wealth Advisors reduced its Altimmune (ALT) stake by 2.6% in Q2 2026, selling an estimated $5.97K and leaving 74,500 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #907.

Kingswood Wealth Advisors first reported a position in ALT in Q2 2025 and has held it in 5 quarters since. The position peaked at $236K in Q1 2026. 38 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Kingswood Wealth Advisors held 74,500 shares of Altimmune worth $226K as of Q2 2026.
Kingswood Wealth Advisors sold 2,000 Altimmune shares in Q2 2026, an estimated $5.97K.
Altimmune made up 0.01% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #907 holding.
Kingswood Wealth Advisors first reported a position in Altimmune in Q2 2025 and has held it in 5 quarters since.
Kingswood Wealth Advisors's Altimmune position peaked at $236K in Q1 2026.
38 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.